Lamotrigine Tablet
Product Images NDC 55111-223

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 55111-223). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Packaging label for Lamotrigine Tablets USP, 25 mg, oral tablets by Dr. Reddy's Laboratories Limited. The label indicates 100 tablets per carton (10 blister cards of 10 tablets each), with NDC 55111-220-78. It includes storage instructions, caution for pharmacists to verify product dispensation, and barcode. Manufactured in India.*

FDA Label Image

Carton2 (Carton2)

Lamotrigine Tablets USP, 100 mg oral tablets packaging label by Dr. Reddy's Laboratories Limited. The carton contains 100 tablets divided into 10 unit doses. The label includes dosage strength, NDC 55111-221-78, cautions for pharmacists, storage instructions, and manufacturer information from India.*

FDA Label Image

Carton3 (Carton3)

Packaging label for Lamotrigine Tablets USP 150 mg oral tablets by Dr. Reddy's Laboratories Limited. The label indicates 100 tablets (10 x 10 unit-dose blister packs) with dosage and storage instructions. It includes a caution to verify the product dispensed and instructions for pharmacists to dispense the medication guide.*

FDA Label Image

Carton4 (Carton4)

Packaging label for Lamotrigine Tablets USP 200 mg, oral tablets supplied in 100 tablets per carton (10 x 10 unit-dose). Label shows NDC 55111-223-78, manufactured by Dr. Reddy's Laboratories Limited, India. Includes storage instructions, cautions for pharmacists, and barcode on the carton.*

FDA Label Image

Container1 (Container1)

Lamotrigine 25 mg oral tablets bottle label by Dr. Reddy's Laboratories Limited. The label indicates 100 tablets per container, with a caution to verify the product dispensed and pharmacist instructions to dispense the accompanying medication guide. It includes storage directions and regulatory information along with the NDC 55111-220-01.*

FDA Label Image

Container2 (Container2)

Lamotrigine Tablets USP, 100 mg oral tablets label from Dr. Reddy's Laboratories Limited. The label includes NDC 55111-221-01 and cautions to verify product dispensed. It instructs pharmacists to dispense the Medication Guide to each patient. Storage and dispensing information is provided along with the manufacturer details and barcode.*

FDA Label Image

Container3 (Container3)

Lamotrigine Tablets USP, 150 mg oral tablets label from Dr. Reddy's Laboratories Limited. The label states the quantity as 100 tablets and includes the NDC 55111-222-01. It features cautionary text for pharmacists to verify the product and dispense an accompanying medication guide. Storage and dispensing instructions are also present, along with manufacturer and barcode information.*

FDA Label Image

Container4 (Container4)

Lamotrigine Tablets USP, 200 mg, oral tablets by Dr. Reddy's Laboratories Limited. The label indicates it contains 100 tablets per bottle. It includes a caution to verify the dispensed product and an instruction for pharmacists to provide an accompanying medication guide. Storage instructions specify keeping the container at controlled room temperature, 20° to 25°C, with excursions permitted between 15° to 30°C, in a dry and light-protected place.*

FDA Label Image

Fig1

A Kaplan-Meier survival curve comparing failure probability (%) over weeks between Lamotrigine and Placebo groups. The graph shows two lines representing cumulative failure probabilities, with censored data indicated. The x-axis represents weeks (0 to 100), and the y-axis represents failure probability from 0% to 100%.*

FDA Label Image

Fig2

A Kaplan-Meier failure probability graph comparing Lamotrigine to placebo over approximately 80 weeks. The y-axis shows failure probability in percentage, and the x-axis shows the duration in weeks. The graph features two survival curves, one labeled Lamotrigine and the other Placebo, with censored data points marked.*

FDA Label Image

Structure (Structure)

Chemical structure of Lamotrigine, showing a triazine ring with amino and dichlorophenyl substituents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.